Biolife Solutions
(BLFS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,448 | 30,657 | 6,663 | 1,406 | 2,173 |
| Marketable Securities | N/A | N/A | N/A | N/A | 1,651 |
| Receivables | 5,345 | 3,045 | 1,021 | 1,194 | 929 |
| Inventories | 10,972 | 3,509 | 1,847 | 1,758 | 1,835 |
| TOTAL | $24,113 | $37,564 | $9,931 | $4,628 | $6,973 |
| Non-Current Assets | |||||
| PPE Net | 5,572 | 1,319 | 1,106 | 1,187 | 1,446 |
| Investments And Advances | 2,500 | 6,548 | 1,070 | 2,075 | 0 |
| Intangibles | 55,619 | 0 | 0 | 0 | 2,215 |
| Other Non-Current Assets | 5,012 | 36 | 36 | 36 | 1,735 |
| TOTAL | $68,703 | $7,903 | $2,212 | $3,299 | $5,397 |
| Total Assets | $92,816 | $45,467 | $12,143 | $7,927 | $12,370 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,119 | 720 | 691 | 711 | 1,029 |
| Accrued Expenses | 3,369 | 1,219 | 692 | 292 | 566 |
| Other current liabilities | 377 | N/A | 130 | 130 | 130 |
| TOTAL | $7,669 | $1,939 | $1,513 | $1,133 | $1,726 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,844 | N/A |
| Other Non-Current Liabilities | 41,693 | 28,896 | 538 | 1,949 | 1,566 |
| TOTAL | $41,693 | $28,896 | $538 | $3,627 | $785 |
| Total Liabilities | $49,362 | $30,835 | $2,051 | $4,761 | $2,510 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,000 | 18,652 | 14,121 | 13,000 | 12,448 |
| Common Shares | 21 | 19 | 14 | 13 | 12 |
| Retained earnings | -100,052 | -98,395 | -73,958 | -71,202 | -64,327 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 1,351 |
| TOTAL | $43,454 | $14,632 | $10,092 | $3,166 | $9,859 |
| Total Liabilities And Equity | $92,816 | $45,467 | $12,143 | $7,927 | $12,370 |